This paper aims to discuss the role of diagnostic imaging in screening protocols for early detection of cancer of the breast, colon and rectum, prostate and lung. The latest attitude of scientists and public health managers towards screening programmes is mainly driven by evidence results, but randomised trials are often difficult to start due to ethical reasons, and difficult to conclude because of the merging new technologies and the long time required. While mammography, even if sometimes controversial, is nowadays a consolidated tool for early diagnosis of breast cancer, other diagnostic techniques, such as low-dose computed tomography for detection of lung cancer, need to prove their efficacy and avoid extended times required to obtain evidence-based results.

Author

M Bellomi, L Preda, E De Fiori, F Facciolo

Contact Details

Corresponding address:
Massimo Bellomi
European Institute of Oncology,
Via Ripamonti 435,
20141 Milan,
Italy

Email: massimo.bellomi@ieo.it

Reference

ICIS Cancer Imaging Volume 4 Special Issue B
DOI: 10.1102/1470-7330.2004.0023

Date Posted

3 January 2005

Print PDF

Size

5.98 MB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	23 seconds
ADSL 512Kb/s (Broadband):	1 minute 35 seconds
64 Kb/s (ISDN):	12 minutes 45 seconds
33.3 Kb/s (Typical Modem):	24 minutes 31 seconds

Screen PDF

Size

304.15 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	1 second
ADSL 512Kb/s (Broadband):	4 seconds
64 Kb/s (ISDN):	38 seconds
33.3 Kb/s (Typical Modem):	1 minute 13 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 61053, London, SE16 7YZ. Tel: +44 (0)207 719 8989 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.